Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
Top Cited Papers
Open Access
- 8 December 2005
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 116 (1) , 59-69
- https://doi.org/10.1172/jci25074
Abstract
The majority of acute clinical manifestations of atherosclerosis are due to the physical rupture of advanced atherosclerotic plaques. It has been hypothesized that macrophages play a key role in inducing plaque rupture by secreting proteases that destroy the extracellular matrix that provides physical strength to the fibrous cap. Despite reports detailing the expression of multiple proteases by macrophages in rupture-prone regions, there is no direct proof that macrophage-mediated matrix degradation can induce plaque rupture. We aimed to test this hypothesis by retrovirally overexpressing the candidate enzyme MMP-9 in macrophages of advanced atherosclerotic lesions of apoE–/– mice. Despite a greater than 10-fold increase in the expression of MMP-9 by macrophages, there was only a minor increase in the incidence of plaque fissuring. Subsequent analysis revealed that macrophages secrete MMP-9 predominantly as a proform, and this form is unable to degrade the matrix component elastin. Expression of an autoactivating form of MMP-9 in macrophages in vitro greatly enhances elastin degradation and induces significant plaque disruption when overexpressed by macrophages in advanced atherosclerotic lesions of apoE–/– mice in vivo. These data show that enhanced macrophage proteolytic activity can induce acute plaque disruption and highlight MMP-9 as a potential therapeutic target for stabilizing rupture-prone plaques.Keywords
This publication has 69 references indexed in Scilit:
- Myeloperoxidase and Plaque VulnerabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascadeExperimental Cell Research, 2004
- Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous AntigenScandinavian Journal of Immunology, 2004
- Stabilization of atherosclerotic plaques: New mechanisms and clinical targetsNature Medicine, 2002
- Substrate Binding of Gelatinase B Induces Its Enzymatic Activity in the Presence of Intact PropeptideJournal of Biological Chemistry, 2002
- Effect of γ-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient miceThe Journal of Pathology, 2001
- Increased Matrix Metalloproteinase-9 Activity in Unstable Carotid PlaquesStroke, 2000
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994